| Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel H Döhner, E Estey, D Grimwade, S Amadori, FR Appelbaum, T Büchner, ... Blood, The Journal of the American Society of Hematology 129 (4), 424-447, 2017 | 5709 | 2017 |
| Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet H Döhner, EH Estey, S Amadori, FR Appelbaum, T Büchner, AK Burnett, ... Blood, The Journal of the American Society of Hematology 115 (3), 453-474, 2010 | 4240 | 2010 |
| Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ... New England Journal of Medicine 377 (5), 454-464, 2017 | 2126 | 2017 |
| Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials J Koreth, R Schlenk, KJ Kopecky, S Honda, J Sierra, BJ Djulbegovic, ... Jama 301 (22), 2349-2361, 2009 | 1096 | 2009 |
| International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ... Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022 | 1084 | 2022 |
| Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN H Döhner, AH Wei, FR Appelbaum, C Craddock, CD DiNardo, H Dombret, ... Blood, The Journal of the American Society of Hematology 140 (12), 1345-1377, 2022 | 1039 | 2022 |
| Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with … BL McClune, DJ Weisdorf, TL Pedersen, G Tunes da Silva, MS Tallman, ... Journal of Clinical Oncology 28 (11), 1878-1887, 2010 | 538 | 2010 |
| Antilymphocyte globulin for prevention of chronic graft-versus-host disease N Kröger, C Solano, C Wolschke, G Bandini, F Patriarca, M Pini, A Nagler, ... New England Journal of Medicine 374 (1), 43-53, 2016 | 523 | 2016 |
| The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach JJ Cornelissen, A Gratwohl, RF Schlenk, J Sierra, M Bornhaeuser, ... Nature reviews Clinical oncology 9 (10), 579-590, 2012 | 468 | 2012 |
| Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose J Sierra, B Storer, JA Hansen, JW Bjerke, PJ Martin, EW Petersdorf, ... Blood, The Journal of the American Society of Hematology 89 (11), 4226-4235, 1997 | 446 | 1997 |
| Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical … R Martino, S Iacobelli, R Brand, T Jansen, A van Biezen, J Finke, ... Blood 108 (3), 836-846, 2006 | 426 | 2006 |
| Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice T Ruutu, A Gratwohl, T De Witte, B Afanasyev, J Apperley, A Bacigalupo, ... Bone marrow transplantation 49 (2), 168-173, 2014 | 389 | 2014 |
| Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies L Munoz, JF Nomdedéu, O López, MJ Carnicer, M Bellido, A Aventín, ... Haematologica 86 (12), 1261-1269, 2001 | 360 | 2001 |
| Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a … S Brunet, M Labopin, J Esteve, J Cornelissen, G Socié, AP Iori, ... Journal of clinical oncology 30 (7), 735-741, 2012 | 359 | 2012 |
| Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a … A Advani, B Coiffier, MS Czuczman, M Dreyling, J Foran, E Gine, ... Journal of Clinical Oncology 28 (12), 2085-2093, 2010 | 346 | 2010 |
| Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia J Sierra, WS Pérez, C Rozman, E Carreras, JP Klein, JD Rizzo, ... Blood, The Journal of the American Society of Hematology 100 (6), 1997-2004, 2002 | 343 | 2002 |
| Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post … M Pratcorona, S Brunet, J Nomdedéu, JM Ribera, M Tormo, R Duarte, ... Blood, The Journal of the American Society of Hematology 121 (14), 2734-2738, 2013 | 310 | 2013 |
| Autologous stem-cell transplantation for Hodgkin’s disease: results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula … A Sureda, R Arranz, A Iriondo, E Carreras, JJ Lahuerta, J Garcia-Conde, ... Journal of clinical oncology 19 (5), 1395-1404, 2001 | 283 | 2001 |
| Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse A Sureda, M Constans, A Iriondo, R Arranz, MD Caballero, MJ Vidal, ... Annals of Oncology 16 (4), 625-633, 2005 | 271 | 2005 |
| Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic … D Valcárcel, R Martino, D Caballero, J Martin, C Ferra, JB Nieto, ... Journal of Clinical Oncology 26 (4), 577-584, 2008 | 269 | 2008 |
